# Duchenne muscular dystrophy

Type: Technology

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/duchenne-muscular-dystrophy
Canonical HTML page: https://gethealthbrief.com/entity/duchenne-muscular-dystrophy

## Recent coverage (1 stories)

### Senator Ron Johnson Launches Investigation Into FDA Rare Disease Drug Denials
2026-03-10 22:18:15 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

Senator Ron Johnson (R-Wis.) has initiated a formal investigation into the FDA's handling of biologic therapy applications for rare diseases, specifically targeting Duchenne muscular dystrophy. The probe follows a direct consultation with FDA Commissioner Marty Makary regarding perceived regulatory barriers for life-saving treatments.
Full story: https://gethealthbrief.com/story/ron-johnson-fda-rare-disease-investigation

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.